Senior Research Analyst
Direct: (312) 894-7657
- Medical Technology
- Digital Health
- Accuray Incorporated (ARAY)
- Augmedix Inc. (AUGX)
- Butterfly Network, Inc. (BFLY)
- CareCloud (CCLD),
- ClearPoint Neuro (CLPT)
- Establishment Labs Holdings, Inc. (ESTA)
- Hyperfine, Inc. (HYPR)
- OptimizeRx Corporation (OPRX)
- Paragon 28, Inc. (FNA)
- PROCEPT BioRobotics Corporation (PRCT)
- Silk Road Medical (SILK)
- Stereotaxis, Inc. (STXS)
- ViewRay, Inc. (VRAY)
Neil Chatterji is a Senior Equity Research Analyst in the Healthcare Research Group with B. Riley Securities responsible for coverage of Medical Technology and Digital Health. He has almost a decade of experience in equity research with a focus in healthcare. He joined the healthcare equity research team in 2022 to focus on coverage of emerging SMiD-cap medical device and digital health companies with differentiated technologies.
Prior to B. Riley, he mostly recently was at Cowen as a Vice President in research covering Medical Devices, covering all cap companies focused on a range of technologies including for cardiology, orthopedics, and robotics / digital health. He has also held research positions at BMO (MedTech), Sidoti (Digital Health / HCIT), and Craig-Hallum, and in investor relations at AbbVie. Prior to his roles in equity research, he worked in healthcare strategy for providers and payors and in hospital administration.
Mr. Chatterji is a member of the Leadership Board for the Applied Security Analysis Program at the University of Madison-Wisconsin, and a philanthropic advocate for the Colorectal Cancer Alliance. He received his MBA from the University of Madison-Wisconsin, participating in the esteemed Applied Security Analysis Program, an MHA in healthcare management from the George Washington University, and a B.S. in business administration in finance and economics from the Ohio State University.